Technology

When things go right, early stage companies like InspireMD eventually have to transition from developers to functioning commercial operations. This means taking a cleaver to operational elements that aren’t essential, so consolidating manufacturing and outsourcing physical distribution.

Royal Philips has chosen the EuroPCR event in its home country, at which to launch of EPIQ ultrasound system. The company claims EPIQ offers an entirely new level of clinical confidence with a first-of-its-kind ultrasound architecture that is a totally new approach to creating ultrasound images without compromise.

Theradome™ Inc has seen its LH80 laser helmet gain FDA’s clearance, bringing a so-called “clinical strength” therapy to the home for a fraction of the cost of visiting a hair restoration clinic.

AngioDynamics, Inc. has announced the U.S. FDA 510(k) clearance through its subsidiary business Navilyst Medical Inc., for its BioFlo Port with Endexo technology, which is designed to reduce the accumulation of catheter-related thrombus on, and in, the port catheter.

Cardium Therapeutics has reported on a research collaboration with researchers at Boston Children’s Hospital, to assess the medical utility of Excellagen® as a delivery scaffold to seed autologous mesenchymal fetal stem cells for ex-vivo engineering of tissue grafts for transplantation into infants to repair prenatally diagnosed birth defects.

Less than two years ago we were reporting the news that Apnex Medical Inc had gained CE mark approval for … continue reading “Apnex Breathes its Last”

A new report, entitled the 2013 Smart Pump/EMR Integration Report from KLAS Research cites CareFusion as the technology leader that is poised to take the lead in integrating smart pumps with electronic medical records (EMR) and the only company that currently has a customer using EMR interoperability with large volume and syringe infusion pumps.

We’ve found an interesting piece in the New York Times Business daily about a device intended to aid diagnosis of … continue reading “Melanoma Detection Device Questioned”

We spotted a piece in Jewish Business News covering the tale of an Israeli firm which has developed a method … continue reading “Another New Technology Promises End For Staples And Stitches”

A new market intelligence report provides the landscape and market trends on the three MRI systems market segments: low-field MRI systems, mid-field MRI systems and high-field MRI systems segments.

Sealantis Ltd., a private start-up from the Technion-Israel Institute of Technology, reports that an eighth patient was treated with Seal-V, its alga-mimetic vascular sealant, as part of the company’s first clinical study. Seal-V is a protein-free sealant, designed to resolve current limitations and challenges in control of surgical bleeding. It is expected to receive CE Mark within the year.

Device innovator Medspira has announced a multi-center randomized clinical trial utilizing an investigational biofeedback device combined with pelvic floor physical therapy for treatment of fecal incontinence.

Artificial Vital Organs and Medical Bionics Market is Expected to Reach USD 32.3 Billion Globally in 2018: Transparency Market Research … continue reading “Artificial Vital Organs and Medical Bionics Market to Reach USD 32.3 Bn in 2018”

Aethlon Medical, Inc. has announced that the U.S. FDA has approved an Investigational Device Exemption (IDE) that allows the Company to initiate human feasibility studies of the Aethlon Hemopurifier® in the country. The Hemopurifier targets the rapid elimination of life-threatening infectious disease and cancer glycopathogens from circulation.

Cynosure, Inc., minimally invasive and non-invasive aesthetic device company, has completed its acquisition of Palomar Medical Technologies, Inc. in a move that it hopes will cement its place as one of the premier aesthetic laser and light-based companies.

Assessing the impact of medtech innovation on rising healthcare expenditure requires looking beyond cost alone, according to new research.